Amalgamated Bank Reduces Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)

Amalgamated Bank decreased its position in Privia Health Group, Inc. (NASDAQ:PRVA) by 4.1% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 31,603 shares of the company’s stock after selling 1,343 shares during the quarter. Amalgamated Bank’s holdings in Privia Health Group were worth $549,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently bought and sold shares of PRVA. Vanguard Group Inc. increased its stake in Privia Health Group by 1.1% in the first quarter. Vanguard Group Inc. now owns 11,400,035 shares of the company’s stock valued at $223,327,000 after purchasing an additional 121,701 shares during the last quarter. Riverbridge Partners LLC increased its stake in shares of Privia Health Group by 17.5% during the 1st quarter. Riverbridge Partners LLC now owns 5,399,662 shares of the company’s stock valued at $105,779,000 after acquiring an additional 804,304 shares during the last quarter. Norges Bank purchased a new position in shares of Privia Health Group during the 4th quarter worth about $27,959,000. Dimensional Fund Advisors LP boosted its position in shares of Privia Health Group by 18.4% in the second quarter. Dimensional Fund Advisors LP now owns 1,118,619 shares of the company’s stock worth $19,441,000 after acquiring an additional 173,934 shares during the last quarter. Finally, First Light Asset Management LLC acquired a new position in Privia Health Group during the first quarter worth approximately $21,620,000. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Stock Performance

Shares of PRVA opened at $18.08 on Monday. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $24.35. The stock has a 50-day moving average price of $19.46 and a 200 day moving average price of $18.52. The company has a market capitalization of $2.16 billion, a P/E ratio of 120.53, a P/E/G ratio of 4.24 and a beta of 0.77.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.02). The company had revenue of $422.30 million for the quarter, compared to the consensus estimate of $411.50 million. Privia Health Group had a net margin of 0.88% and a return on equity of 2.42%. The company’s revenue was up 2.2% compared to the same quarter last year. During the same quarter last year, the company earned $0.06 earnings per share. As a group, equities research analysts forecast that Privia Health Group, Inc. will post 0.16 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Privia Health Group news, CEO Parth Mehrotra sold 135,142 shares of the stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the sale, the chief executive officer now directly owns 247,771 shares of the company’s stock, valued at $4,583,763.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 14.20% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Royal Bank of Canada restated an “outperform” rating and set a $28.00 price objective on shares of Privia Health Group in a report on Wednesday, August 14th. Evercore ISI decreased their target price on Privia Health Group from $23.00 to $20.00 and set an “outperform” rating for the company in a report on Tuesday, July 9th. Finally, Robert W. Baird raised their price target on shares of Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, August 26th. Two equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $24.86.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.